According to Future Market Insights research, during the projected period, the global enteric softgel capsules market is expected to grow at a CAGR of 6.7%. The market value is projected to increase from USD 305.3 million in 2023 to USD 582.5 million by 2033. The enteric softgel capsules market was valued at USD 288.8 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.7% in 2023.
Market Outlook:
Key Market Attributes
| Market Size, 2022 | USD 288.8 Million |
|---|---|
| Market Size, 2023 | USD 305.3 Million |
| Market Size, 2033 | USD 582.5 Million |
| Value CAGR (2023 to 2033) | 6.7% |
Soft gelatin capsules are used to contain powders or water-insoluble liquids that have been dissolved in a non-polar solvent for a number of purposes, including disguising tastes or offensive odors, lowering product contamination, and safeguarding the active medication against oxidation.
In order to limit gastrointestinal irritation from the medication and to prevent the active ingredients from being degraded by the gastric juice, gastric-resistant capsules are utilized. Only at enteric pH may the medication be released due to the gastric-resistant coating.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global enteric softgel capsules market recorded a historic CAGR of 5.7% in the last 5 years from 2017 to 2022. The market value for the enteric softgel capsules market was around 25.8% of the overall USD 1.1 billion of the global softgel capsules market.
Semi Annual Market Update
| Particulars | Value CAGR |
|---|---|
| H1 | 6.22% (2022 to 2032) |
| H2 | 6.98% (2022 to 2032) |
| H1 | 5.99% (2023 to 2033) |
| H2 | 7.35% (2023 to 2033) |
A dynamic and quickly developing sector of the pharmaceutical and nutraceutical industries is the enteric softgel capsules industry. The enteric coating on these specialty capsules allows them to pass through the stomach unharmed and dissolve in the intestines, allowing the best possible absorption of the active components.
The market is expected to increase due to factors such as the rising need for cutting-edge medication delivery systems, the rising acceptance of dietary supplements, and the requirement for efficient treatments for gastrointestinal illnesses.
In order to satisfy consumer preferences for simple administration and improved bioavailability, enteric softgel capsules provide a flexible and practical choice for delivering delicate medications and nutrients.
The enteric softgel capsules market offers prospective opportunities for pharmaceutical businesses, supplement makers, and customers seeking effective and tailored treatment outcomes due to ongoing improvements in manufacturing technology and research initiatives.
The market for enteric softgel capsules is significantly influenced by the global increase in gastrointestinal illnesses. There is a rising need for efficient drug delivery methods that may target the intestines while avoiding the harsh stomach environment as the prevalence of illnesses including acid reflux, ulcerative colitis, and Crohn's disease continues to rise globally.
By applying specific coatings, enteric softgel capsules provide a remedy by ensuring the safe transit of active components to the intestines and preventing early disintegration in the stomach. This makes it possible to treat gastrointestinal problems effectively and improve the therapeutic effects of drugs.
Thus, the potential of enteric softgel capsules to enhance bioavailability and ensure that pharmaceuticals are delivered where they are most required, aligning with the growing healthcare needs of a population dealing with gastrointestinal health conditions globally, is what drives demand for these products.
Principal Consultant
The enteric softgel capsules market is significantly constrained in its ability to grow due to limited compatibility. The compatibility of formulations with enteric coating materials limits the use of these capsules, despite the fact that they present a promising method for the targeted delivery of medications and the protection of delicate constituents.
On other hand, some active components might not be good candidates for enteric softgel encapsulation, particularly if they are sensitive to certain coatings or unable to tolerate the enteric process. This restriction may hamper the development of novel medications and nutraceuticals that could benefit from enteric delivery as well as the growth of product offers.
Formulators and manufacturers must overcome these obstacles, which could result in extended research and development cycles, increased costs, and less market opportunities. Unlocking the full potential of enteric softgel capsules in various therapeutic applications is dependent on improvements in enteric coating materials and methods that address limited compatibility.
| Countries | Value CAGR |
|---|---|
| United States | 8.7% |
| Germany | 6.3% |
| United Kingdom | 6.9% |
| Japan | 7.1% |
| China | 6.7% |
| India | 6.7% |
The United States dominates the global market with a 28.5% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period.
The United States pharmaceutical and nutraceutical industries are developing, which is boosting the demand for enteric softgel capsules. There is an increasing need for efficient and specialized delivery systems, such as enteric softgel capsules, as these sectors continue to create novel medications and supplements.
These capsules shield delicate chemicals from stomach acids, ensuring ideal intestinal absorption and boosting medicinal effectiveness. This need is also fueled by the trend toward targeted medicines and customized medicine.
Since the United States is a prominent center for pharmaceutical and nutraceutical research, development, and manufacture, the growing use of enteric softgel capsules is consistent with the sectors' desire for cutting-edge and effective drug delivery solutions, greatly boosting market growth.
China dominates the global market with 8.1% of the market share in 2022. The rising demand for nutritional supplements in China, fueled by increasing awareness of malnutrition-related concerns, drives the growth of the enteric softgel capsules market.
These capsules offer effective nutrient delivery, aiding in combatting malnutrition by ensuring optimal absorption in the intestines. As consumers prioritize wellness and seek convenient dosage forms, enteric softgel capsules play a crucial role in addressing nutritional deficiencies, aligning with China's efforts to improve public health and nutrition outcomes.
India holds about 6.9% share of the global market in 2022 and is projected to increase during the forecast period. The increase in the incidence of inflammatory bowel disease (IBD) is driving the market for enteric softgel capsules in India.
The need for targeted medicine delivery to the intestines is growing as IBD, which includes diseases like Crohn's disease and ulcerative colitis, grows increasingly common.
With their protective coating, enteric softgel capsules allow for efficient medication release in the lower digestive tract, improving therapeutic results and patient comfort. The use of enteric softgel capsules in the Indian pharmaceutical market is being driven by the expanding demand for specific medication delivery methods that are in line with the increase in IBD cases.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Growth Outlook by Key Product
| Product | Value CAGR |
|---|---|
| Gelatin Softgel Capsules | 5.6% |
| Vegetarian Softgel Capsules | 10.0% |
Gelatin softgel capsules within the product segment hold a revenue share of 74.3% in 2022, and the same trend is being followed over the forecasted period. Gelatin softgel capsules' dominance in the enteric softgel capsule industry can be due to its successful record of accomplishment, widespread acceptability, and affordability.
Gelatin is frequently used to deliver delicate substances while maintaining good absorption in the intestines due to its compatibility with enteric coatings and its established manufacturing procedures.
Market Growth Outlook by Key Raw Material
| Raw Material | Value CAGR |
|---|---|
| Type-A Gelatin (Pork Skin) | 5.0% |
| Type-B Gelatin (Animal Bones & Skin) | 6.2% |
| Fish Bone Gelatin | 7.3% |
| Cellulose Derivatives | 9.4% |
| Starch Material | 11.4% |
Type-A Gelatin (Pork Skin) held a market share of 42.9% in 2022 due to its wide availability, compatibility with enteric coating procedures, and affordability, Type-A Gelatin (Pork Skin) is a recommended option for formulation because it provides consistent performance in establishing intestinal barriers, guaranteeing adequate drug release, and adhering to regulatory criteria.
Market Growth Outlook by Key Application
| Application | Value CAGR |
|---|---|
| Antacid & Antiflatulent Preparations | 4.6% |
| Anti-inflammatory Drugs | 3.7% |
| Antibiotic & Antibacterial Drugs | 2.8% |
| Cough & Cold Preparations | 6.9% |
| Health Supplements | 7.5% |
| Vitamin & Dietary Supplements | 8.2% |
| Other Therapeutic Applications | 1.6% |
The vitamin and Dietary Supplements segment dominates the application segment holding 33.3% market share in 2022. The enteric softgel capsules market is dominated by the vitamin and dietary supplements segment as a result of rising consumer interest in health and wellness as well as the convenience and improved absorption provided by enteric coatings.
These capsules efficiently distribute and safeguard delicate nutrients, meeting the requirement for efficient nutritional dietary supplements.
Market Growth Outlook by Key End User
| End User | Value CAGR |
|---|---|
| Pharmaceutical Companies | 8.3% |
| Nutraceutical Companies | 5.8% |
| Cosmeceutical Companies | 4.4% |
| Food Industry | 6.8% |
Pharmaceutical companies segment dominate the dosage segment holding 33.6% market share in 2022. Due to their extensive research, strong drug development skills, and broad drug pipelines, pharmaceutical companies dominate the end-user segment for enteric softgel capsules.
The precise medication distribution provided by enteric softgel capsules improves therapeutic results and is in line with pharmaceutical companies' emphasis on cutting-edge formulations for efficient therapies and patient care.
Strategic partnerships are a priority for leading enteric softgel capsules companies as they work to create new product lines and expand their global consumer base.
Similarly, recent developments related to companies in the enteric softgel capsules market have been tracked by the team at Future Market Insights, which are available in the full report.
Related Market Growth Outlook Scenario
| Particulars | Value CAGR |
|---|---|
| Softgel Capsules Market | 5.9% |
| Hard Gelatin Capsules Market | 6.3% |
| Empty Capsules Market | 7.9% |
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Product, Raw Material, Application, End User, and Region |
| Key Companies Profiled | GELITA AG, Catalent Inc, Renown Pharmaceuticals Pvt. Ltd., InovoBiologic Inc, Viva Pharmaceutical,, Aenova Group, Basf Se, Lonza Group Ltd, Procaps Laboratory, Sirio Pharma Co Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is currently valued at around USD 288.8 million in 2022.
The global market is set to reach a valuation of around USD 582.5 million by the end of 2033.
Gelatin softgel capsules segment, within the product segment, held 74.3% share of the global market in 2022.
Demand for the global market increased at a 5.7% CAGR from 2017 to 2022.
The global estimate for 2023 is around USD 305.3 Million.
The United States accounts for around 28.5% share of the global market in 2022.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 7.1. Gelatin Softgel Capsules 7.2. Vegetarian Softgel Capsules 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Raw Material 8.1. Type-A Gelatin (Pork Skin) 8.2. Type-B Gelatin (Animal Bones and Skin) 8.3. Fish Bone Gelatin 8.4. Cellulose Derivatives 8.5. Starch Material 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 9.1. Antacid and Antiflatulent Preparations 9.2. Anti-inflammatory Drugs 9.3. Antibiotic and Antibacterial Drugs 9.4. Cough and Cold Preparations 9.5. Health Supplements 9.6. Vitamin and Dietary Supplements 9.7. Other Therapeutic Applications 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 10.1. Pharmaceutical Companies 10.2. Nutraceutical Companies 10.3. Cosmeceutical Companies 10.4. Food Industry 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia 11.6. Oceania 11.7. Middle East and Africa 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Market Structure Analysis 20. Competition Analysis 20.1. GELITA AG 20.2. Catalent, Inc 20.3. Renown Pharmaceuticals Pvt. Ltd. 20.4. InovoBiologic Inc 20.5. Viva Pharmaceutical 20.6. Aenova Group 20.7. Basf Se 20.8. Lonza Group Ltd 20.9. Procaps Laboratory 20.10. Sirio Pharma Co Ltd. 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Enteric Softgel Capsules Market
